IP Library Granted Patent US 7,807,685
Granted Patent B2
US 7,807,685 · App. 11/823,377 · Granted Oct 5, 2010

Therapeutic compounds

Assignee: CBT Development Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,685
App. No.
11/823,377
Granted
Oct 5, 2010
Kind
B2
Abstract

Compounds of formula (I) below are disclosed. Their use as medicaments is described, in particular for the treatment of pain or inflammation: wherein: when X=Y=Z=OH, R 1 is OCH 2 CF 2 CF 3 , phenoxy (substituted with 3-(4-trifluoromethylphenyl), 3,4-dichloro, (3-trifluoromethyl,4-fluoro), (3-trifluoromethyl,4-chloro), (3-chloro, 4-cyano), or 3,5-bis(trifluoromethyl)), 1-piperazinyl(4-(3,4-dichlorophenyl)), phenyl (substituted with 3,4-dichloro, 3,5-difluoro, 3,5-bis(trifluoromethyl) or 3,4,5-trifluoro) or 2-benzofuranyl; or when X=Y=OH and Z=OMe, R 1 is OCH 3 , OCH 2 CHF 2 , OCH 2 cyclopentyl, O-(2,5-difluorophenyl) or (S)-sec-butylamino; or when X=H and Y=Z=OH, R 1 is n-hexylamino or cyclopentylamino; or when (IV) X=Z=OH and Y=H, R 1 is cyclopentylamino; or a pharmaceutically acceptable salt thereof.

Claims (10)

1. A compound of the following general formula:

wherein:

when X=Y=Z=OH, R1 is OCH2CF2CF3, phenoxy (substituted with 3-(4-trifluoromethylphenyl), 3,4-dichloro, (3-trifluoromethyl,4-fluoro), (3-trifluoromethyl,4-chloro), (3-chloro, 4-cyano), or 3,5-bis(trifluoromethyl)), 1-piperazinyl(4-(3,4-dichlorophenyl)), phenyl (substituted with 3,4-dichloro, 3,5-difluoro, 3,5-bis(trifluoromethyl) or 3,4,5-trifluoro) or 2-benzofuranyl; or

when X=H and Y=Z=OH, R1 is n-hexylamino or cyclopentylamino; or

when X=Z=OH and Y=H, R1 is cyclopentylamino;

or a pharmaceutically acceptable salt thereof.

2. A compound according to claim 1 , wherein each of X, Y and Z is OH.

3. A pharmaceutical composition comprising a compound according to claim 1 , and a physiologically acceptable carrier, excipient, or diluent.

4. The pharmaceutical composition according to claim 3 , further comprising an NSAID or a DMARD.

5. The pharmaceutical composition according to claim 3 , further comprising an anti-pathogenic agent.

Assignments (3)
CHANGE OF NAME Recorded Aug 27, 2010
From: BIOVITRUM AB (PUBL)
To: SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Reel/Frame 024899/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: SWEDISH ORPHAN BIOVITRUM AB (PUBL)
To: CBT DEVELOPMENT LIMITED
Reel/Frame 024899/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2007
From: HIGGINBOTTOM, MICHAEL; SAVORY, EDWARD; BROWN, GILES A; HORGAN, VIET-ANH A; CHAPMAN, EMMA J
To: BIOVITRUM AB (PUBL)
Reel/Frame 020207/0670 →
Priority Claims (1)
SE 0601398 · Jun 27, 2006 · national
Continuity (2)
Provisional Application 6083714600 · Aug 11, 2006
Related Publication 20080076776A1 · Mar 27, 2008